Cannabidiol as a Different Type of an Antipsychotic: Drug Delivery and Interaction Study

NCT02051387 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

74

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Cannabidiol CR
DRUG: Cannabidiol
DRUG: Amisulpride
DRUG: Olanzapine
DRUG: Quetiapine
DRUG: Risperidone
DRUG: Placebo

Sponsor

Central Institute of Mental Health, Mannheim

Collaborators

[object Object]